Pill Identifier Information of Ringl 325 MG Oral Tablet
Drug Information
Ringl 325 MG Oral Tablet
| Imprint: | SATO;N |
| Shape: | C48348 |
| Color: | C48325 |
| Ingredients: | Acetaminophen |
| Size: | 10.00 |
| Score: | 2 |
| Rxtty: | SY |
| Author: | Sato Pharmaceutical Co., Ltd. |
| Inactive Ingredients: | hydroxypropyl cellulose, low substituted / cellulose, microcrystalline / magnesium stearate / polyvinyl alcohol> |
Complete Information
- ACTIVE INGREDIENT
- PURPOSE
-
INDICATIONS & USAGE
Uses
â– for the temporary relief of minor aches and pains associated with:
   ■a cold      ■sore throat   ■headache   ■toothache   ■muscular aches
   ■backache   ■the premenstrual and menstrual periods (dysmenorrhea)
â– for minor pain from arthritis
â– to reduce fever -
WARNINGS
Warnings
Liver warning: This product contains acetaminophen. Severe liver damage may occur if:
   ■adult takes more than 12 tablets in 24 hours, which is the maximum daily amount for this product
   ■child takes more than 5 doses in 24 hours
   ■taken with other drugs containing acetaminophen
   ■adult has 3 or more alcoholic drinks everyday while using this product
Do not use
■with any other drug containing acetaminophen (prescription or nonprescription). If you are not sure whether a drug contains acetaminophen, ask a doctor or pharmacist.Stop use and ask a doctor if
â– pain persists for more than 10 days (for adults) or 5 days (for children)
â– sore throat persists for more than 2 days
â– any of the following occurs (these could be signs of a serious condition):
   ■fever persists for more than 3 days   ■a severe sore throat
   ■sore throat is accompanied or followed by fever, headache, rash, nausea, or vomiting
   ■pain or fever persists or gets worse   ■new symptoms occur
   ■redness or swelling is present
â– when using for pain or arthritis:
   ■pain persists for more than 10 days   ■redness is present
   ■in conditions affecting children under 12 years of age -
DOSAGE & ADMINISTRATION
Directions  Â
adults and children 12 years and over: 1 to 2 tablets every 4 hours, while symptoms persist, not to exceed 6 doses or 12 tablets in 24 hours, or as directed by a doctor  Â
children 11 to under 12 years of age: 1 to 1.5 tablets every 4 hours, while symptoms persist, not to exceed 5 doses or 7.5 tablets in 24 hours, or as directed by a doctor  Â
children 9 to under 11 years of age: 1 tablet every 4 hours, while symptoms persist, not to exceed 5 doses or 5 tablets in 24 hours, or as directed by a doctor  Â
children 6 to under 9 years of age:Â 1 tablet every 4 hours, while symptoms persist, not to exceed 5 doses or 5 tablets in 24 hours, or as directed by a doctor
children 4 to under 6 years of age: 3/4 tablet every 4 hours, while symptoms persist, not to exceed 5 doses or 3.75 tablets in 24 hours, or as directed by a doctor  Â
children 3 to under 4 years of age: 1/2 tablet every 4 hours, while symptoms persist, not to exceed 5 doses or 2.5 tablets in 24 hours, or as directed by a doctor  Â
children under 3 years of age: ask a doctor  Â
- OTHER SAFETY INFORMATION
- INACTIVE INGREDIENT
- PRINCIPAL DISPLAY PANEL
-
INGREDIENTS AND APPEARANCE
RINGLÂ
acetaminophen tabletProduct Information Product Type HUMAN OTC DRUG Item Code (Source) NDC:49873-082 Route of Administration ORAL Active Ingredient/Active Moiety Ingredient Name Basis of Strength Strength ACETAMINOPHEN (UNII: 362O9ITL9D) (ACETAMINOPHEN - UNII:362O9ITL9D) ACETAMINOPHEN 325 mg Inactive Ingredients Ingredient Name Strength HYDROXYPROPYL CELLULOSE, LOW SUBSTITUTED (UNII: 2165RE0K14)  CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  MAGNESIUM STEARATE (UNII: 70097M6I30)  POLYVINYL ALCOHOL (UNII: 532B59J990)  Product Characteristics Color white Score 2 pieces Shape ROUND Size 10mm Flavor Imprint Code SATO;N Contains     Packaging # Item Code Package Description Marketing Start Date Marketing End Date 1 NDC:49873-082-01 1 in 1 CARTON 05/09/1996 1 30 in 1 BOTTLE; Type 0: Not a Combination Product Marketing Information Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date OTC Monograph Drug M013 05/09/1996 Labeler - Sato Pharmaceutical Co., Ltd. (690575642) Establishment Name Address ID/FEI Business Operations Sato Pharmaceutical Co., Ltd. 715699133 manufacture(49873-082) , label(49873-082) , pack(49873-082)
